Midbrain Organoid Dopaminergic Neurons

Midbrain Organoid Dopaminergic Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Midbrain Organoid Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>iPSC > Neural Progenitor > Midbrain Organoid > DA Neuron</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>TH, DAT, GIRK2, PITX3, LMX1A, FOXA2, EN1</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Substantia Nigra pars compacta, Ventral Tegmental Area</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Parkinson's Disease, Dopamine Dysregulation Syndrome</td>
</tr>
</table>

Midbrain Organoid Dopaminergic Neurons

Introduction

Midbrain Organoid Dopaminergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

...

Midbrain Organoid Dopaminergic Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">Midbrain Organoid Dopaminergic Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>iPSC > Neural Progenitor > Midbrain Organoid > DA Neuron</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>TH, DAT, GIRK2, PITX3, LMX1A, FOXA2, EN1</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Substantia Nigra pars compacta, Ventral Tegmental Area</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Parkinson's Disease, Dopamine Dysregulation Syndrome</td>
</tr>
</table>

Midbrain Organoid Dopaminergic Neurons

Introduction

Midbrain Organoid Dopaminergic Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Midbrain organoid dopaminergic neurons are specialized neurons generated within midbrain organoids that model the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA). These neurons produce dopamine, express tyrosine hydroxylase (TH) and the dopamine transporter (DAT), and exhibit the electrophysiological properties characteristic of authentic midbrain dopaminergic neurons["@kriks2011"][@jnsson2019].

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

| Taxonomy | ID | Name / Label |
|----------|----|---------------|
| Cell Ontology (CL) | [CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700) | dopaminergic neuron |

Morphology & Electrophysiology

• Morphology: dopaminergic neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000700)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)
• [OBO Foundry (CL:0000700)](http://purl.obolibrary.org/obo/CL_0000700)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

| Database | ID | Name | Confidence |
|----------|----|------|------------|
| Cell Ontology | [CL:0000700](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700) | dopaminergic neuron | Medium |

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000700)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000700)
• [OBO Foundry (CL:0000700)](http://purl.obolibrary.org/obo/CL_0000700)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Differentiation Protocol

Floor Plate Patterning

Midbrain dopaminergic (mDA) neuron differentiation follows developmental cues:

Days 0-7: Neural rosette formation via dual-SMAD inhibition

Days 7-12: Floor plate induction using SHH and WNT1

Days 12-18: Specification of mDA progenitors (LMX1A+, FOXA2+)

Days 18-30: Differentiation to TH+ mDA neurons

Days 30-60: Maturation and process extension

Key Signaling Factors

• SHH: Ventral patterning
• WNT1: Rostro-caudal patterning
• FGF8: Midbrain specification
• BDNF: Neuronal survival and maturation
• GDNF: Dopaminergic neuron maintenance

Substantia Nigra Pars Compacta (SNc) Neurons

A9 Dopaminergic Population

• Markers: TH, DAT, GIRK2 (KCNJ6), ALDH1A1, SLC6A3
• Function: Motor control, reward learning
• Vulnerability: Selectively degenerate in Parkinson's disease
• Project to: Striatum (nigrostriatal pathway)

Vulnerability Factors

• High mitochondrial demand
• Elevated calcium handling
• Neuromelanin accumulation
• Reduced antioxidant capacity
• Firefly luciferase auto-oxidation

Ventral Tegmental Area (VTA) Neurons

A10 Dopaminergic Population

• Markers: TH, DAT, OTX2, CALB1
• Function: Reward, motivation, addiction
• Less vulnerable in PD than SNc neurons
• Project to: Cortex and limbic structures (mesolimbic pathway)

Parkinson's Disease Modeling

Pathological Features Modeled

• Alpha-synuclein aggregation
• Mitochondrial complex I deficiency
• Elevated oxidative stress
• Reduced dopamine release
• Axonal degeneration

Patient-Specific Models

iPSC-derived mDA neurons from PD patients reveal:

• Increased sensitivity to oxidative stress
• Mitochondrial dysfunction
• Altered protein homeostasis
• Reduced neuronal connectivity[@schultz2018]

Electrophysiological Properties

• Spontaneous pacemaking activity (0.5-10 Hz)
• Broad action potentials (2-5 ms)
• Hyperpolarization-activated cation current (Ih)
• Depolarized resting potential (-40 to -50 mV)
• Dopamine release in response to stimulation

Therapeutic Applications

Cell Replacement Therapy

Clinical trials using mDA neuron transplantation for PD:

• Embryonic stem cell-derived mDA neurons
• iPSC-derived mDA neurons
• Encapsulated cell delivery
• Immunoisolation strategies[@barker2017]

Drug Screening Platforms

Testing of:

• Neuroprotective compounds
• LRRK2 kinase inhibitors
• Alpha-synuclein aggregation blockers
• Mitochondrial function enhancers

See Also

• [Brain Organoid Neurons
• [Nigrostriatal Pathway Dopaminergic Neurons](/cell-types/nigrostriatal-pathway-dopaminergic-neurons)
• Substantia Nigra Pars Reticulata GABAergic Output Neurons](/cell-types/brain-organoid-neurons

--nigrostriatal-pathway-dopaminergic-neurons
--substantia-nigra-pars-reticulata-gabaergic-output-neurons)

• [Parkinson's Disease](/diseases/parkinsons-disease)

Background

The study of Midbrain Organoid Dopaminergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [Michael J. Fox Foundation](https://www.michaeljfox.org/) - Parkinson's research
• [Parkinson's UK](https://www.parkinsons.org.uk/) - Patient resources
• [NIH RePORT](https://report.nih.gov/) - Research funding database